Medicare Enrolled
Dr. Kalil Al-Nassir, MD
Pulmonary Disease · Amarillo, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Al-Nassir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Nassir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Al-Nassir
Dr. Kalil Al-Nassir is a pulmonary disease specialist in Amarillo, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Al-Nassir performed 9,284 Medicare services across 6,413 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Nassir received a total of $35,332 from 16 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Nassir is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 1% volume in TX
$35,332 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,284
Medicare services
Top 1% in TX for pulmonary disease
6,413
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~580 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,821 | $91 | $195 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
828 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
760 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
650 | $67 | $125 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
647 | $26 | $101 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
647 | $37 | $61 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
647 | $37 | $75 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
596 | $8 | $25 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
413 | $17 | $55 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
360 | $4 | $15 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
196 | $24 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
193 | $11 | $37 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
189 | $70 | $86 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
186 | $131 | $224 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
185 | $5 | $16 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
182 | $10 | $37 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
160 | $25 | $90 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
65 | $29 | $30 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
60 | $131 | $175 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
48 | $84 | $287 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
46 | $18 | $39 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
39 | $38 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $124 | $216 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
36 | $3 | $7 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
36 | $71 | $100 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
35 | $34 | $75 |
| New patient office visit, complex (60-74 min) | 32 | $168 | $238 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
27 | $9 | $26 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
27 | $16 | $40 |
| Rheumatoid factor level | 24 | $6 | $45 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
23 | $13 | $50 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
18 | $12 | $30 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
18 | $13 | $45 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
18 | $26 | $32 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
17 | $140 | $176 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
16 | $101 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$35,332
Total received (2018-2024)
Avg $5,047/year across 7 years
Top 8% in TX for pulmonary disease
16
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32,291 (91.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,041 (8.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,779
2023
$7,562
2022
$1,378
2021
$71
2020
$600
2019
$6,925
2018
$11,018
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,450
GlaxoSmithKline, LLC.
$6,267
INTUITIVE SURGICAL, INC.
$4,500
Intuitive Surgical, Inc.
$3,000
Olympus Corporation of the Americas
$1,522
AstraZeneca Pharmaceuticals LP
$1,132
Insmed, Inc.
$177
Regeneron Healthcare Solutions, Inc.
$142
Genentech USA, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$22
Grifols USA, LLC
$21
Baxter Healthcare
$17
Philips Electronics North America Corporation
$16
Siemens Medical Solutions USA, Inc.
$16
GENZYME CORPORATION
$15
Philips North America LLC
$13
Top 3 companies account for 82.7% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · BREZTRI · DUPIXENT · Da Vinci Surgical System · FASENRA · Hillrom - Volara System · ION · NUCALA · OFEV · Prolastin-C Liquid · SOMATOM GO · STIOLTO RESPIMAT · TRELEGY ELLIPTA · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in TX.
Equivalent to $381 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
7
Per 100K population
6.0
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Al-Nassir is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), with speaking/promotional industry engagement in the top 8% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Nassir experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Al-Nassir performed 1,821 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Al-Nassir receive payments from pharmaceutical companies?
Yes. Dr. Al-Nassir received a total of $35,332 from 16 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Nassir's costs compare to other pulmonary diseases in Amarillo?
Dr. Al-Nassir's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Nassir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Amarillo
Browse pulmonary diseases in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology